Advertisement

ADVERTISEMENT

Lauren Mateja, Managing Editor

Cover Story
Climate Change: A Very Real Threat and What Dermatology Can Do
07/16/2021
Lauren Mateja, Managing Editor
Extreme weather patterns, rising sea levels, and mass migration are byproducts of climate change. Dermatologists argue it is time for the specialty to take an active role in this public health crisis affecting current and future generations.
Extreme weather patterns, rising sea levels, and mass migration are byproducts of climate change. Dermatologists argue it is time for the specialty to take an active role in this public health crisis affecting current and future generations.
Extreme weather patterns, rising...
07/16/2021
The Dermatologist
Feature Story
Recognizing the Impact of Diseases in Skin of Color
07/16/2021
Lauren Mateja, Managing Editor
Dermatologic disease in darker skin types can have a profound effect on quality of life. Increased education can help mitigate these effects by recognizing...
Dermatologic disease in darker skin types can have a profound effect on quality of life. Increased education can help mitigate these effects by recognizing...
Dermatologic disease in darker...
07/16/2021
The Dermatologist
Conference Coverage
Conference Preview: Society of Dermatology Physician Assistants Annual Summer Dermatology Conference 2021
06/17/2021
Lauren Mateja, Managing Editor
Physician assistants (PAs) providing dermatologic care can learn from physicians and PA peers about the latest updates in evidence-based practices at the first hybrid conference hosted by the Society of Dermatology Physician Assistants.
Physician assistants (PAs) providing dermatologic care can learn from physicians and PA peers about the latest updates in evidence-based practices at the first hybrid conference hosted by the Society of Dermatology Physician Assistants.
Physician assistants (PAs)...
06/17/2021
The Dermatologist
NEA Approved Features
Dupilumab for Pediatric Atopic Dermatitis: Tips From Dr Amy Paller
06/17/2021
Lauren Mateja, Managing Editor
As the first advanced therapy approved for atopic dermatitis, dupilumab offers an efficacious option for moderate to severe disease. Dr Amy Paller offers insights on how this biologic can help pediatric patients with eczema and their...
As the first advanced therapy approved for atopic dermatitis, dupilumab offers an efficacious option for moderate to severe disease. Dr Amy Paller offers insights on how this biologic can help pediatric patients with eczema and their...
As the first advanced therapy...
06/17/2021
The Dermatologist
Cover Story
Providing Inclusive Care for Sexual and Gender Minority Patients
06/17/2021
Jessica Garlewicz, Associate Digital Editor
Lauren Mateja, Managing Editor
Sexual and gender minority (SGM) people are becoming increasingly visible throughout society. Providers are in a unique position to provide welcoming, inclusive, and comprehensive care for all SGM patients.
Sexual and gender minority (SGM) people are becoming increasingly visible throughout society. Providers are in a unique position to provide welcoming, inclusive, and comprehensive care for all SGM patients.
Sexual and gender minority (SGM)...
06/17/2021
The Dermatologist
DERM - Psoriasis MRC
FDA Alerts
New FDA Approval to Treat Moderate to Severe Pediatric Psoriasis
06/01/2021
Lauren Mateja, Managing Editor
The FDA announced approval of secukinumab, an IL-17 inhibitor, for the treatment of moderate to severe plaque psoriasis in patients aged 6 years and older. The approved dosing is 75 mg or 150 mg, dependent on the child’s weight at dosing...
The FDA announced approval of secukinumab, an IL-17 inhibitor, for the treatment of moderate to severe plaque psoriasis in patients aged 6 years and older. The approved dosing is 75 mg or 150 mg, dependent on the child’s weight at dosing...
The FDA announced approval of...
06/01/2021
The Dermatologist
News
New JAK Inhibitor Shows Efficacy, Safety in Phase 3 Trials for Atopic Dermatitis
06/01/2021
Lauren Mateja, Managing Editor
Upadacitinib, an oral Janus kinase (JAK) 1 inhibitor, was found to be safe and efficacious for the treatment of atopic dermatitis (AD) in two phase 3 clinical trials. The results of the trials were published in The Lancet. The Measure Up 1...
Upadacitinib, an oral Janus kinase (JAK) 1 inhibitor, was found to be safe and efficacious for the treatment of atopic dermatitis (AD) in two phase 3 clinical trials. The results of the trials were published in The Lancet. The Measure Up 1...
Upadacitinib, an oral Janus...
06/01/2021
The Dermatologist
Conference Roundup: SCS, IAS, and AAD VMX 2021
Conference Coverage
Conference Roundup: SCS, IAS, and AAD VMX 2021
05/17/2021
Lauren Mateja, Managing Editor
Continuing education is critical to improving your practice and, ultimately, patient care. This month, The Dermatologist recaps informative sessions from April`s biggest conferences.
Continuing education is critical to improving your practice and, ultimately, patient care. This month, The Dermatologist recaps informative sessions from April`s biggest conferences.
Continuing education is critical...
05/17/2021
The Dermatologist
The Fight for Photoprotection: Pushing for Increased Sunscreen Access
Cover Story
The Fight for Photoprotection: Pushing for Increased Sunscreen Access
05/11/2021
Lauren Mateja, Managing Editor
Photoprotection is a critical part of basic skin care, let alone skin cancer prevention. Improving access to sunscreen products, particularly when it comes to travel, could mean improved outcomes for all patients.
Photoprotection is a critical part of basic skin care, let alone skin cancer prevention. Improving access to sunscreen products, particularly when it comes to travel, could mean improved outcomes for all patients.
Photoprotection is a critical...
05/11/2021
The Dermatologist
What to Expect: Interdisciplinary Autoimmune Summit
What to Expect: Interdisciplinary Autoimmune Summit
03/11/2021
Lauren Mateja, Managing Editor
Immune-mediated inflammatory diseases (IMIDs) rarely affect just one organ system. While dermatologists are not the traditional medical experts in diagnosing and treating diseases such ankylosing spondylitis and...
Immune-mediated inflammatory diseases (IMIDs) rarely affect just one organ system. While dermatologists are not the traditional medical experts in diagnosing and treating diseases such ankylosing spondylitis and...
...
03/11/2021
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
November 6 ⁠–⁠ November 8
NEI Congress
November 7 ⁠–⁠ November 10
ECS
November 8 ⁠–⁠ November 10
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use